Skip to main content

Peer Review reports

From: Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway

Original Submission
6 Jul 2022 Submitted Original manuscript
9 Aug 2022 Reviewed Reviewer Report
25 Aug 2022 Reviewed Reviewer Report
27 Oct 2022 Author responded Author comments - Wenhao Guo
Resubmission - Version 2
27 Oct 2022 Submitted Manuscript version 2
8 Nov 2022 Author responded Author comments - Wenhao Guo
Resubmission - Version 3
8 Nov 2022 Submitted Manuscript version 3
24 Nov 2022 Author responded Author comments - Wenhao Guo
Resubmission - Version 4
24 Nov 2022 Submitted Manuscript version 4
9 Dec 2022 Reviewed Reviewer Report
12 Jan 2023 Author responded Author comments - Wenhao Guo
Resubmission - Version 5
12 Jan 2023 Submitted Manuscript version 5
13 Jan 2023 Author responded Author comments - Wenhao Guo
Resubmission - Version 6
13 Jan 2023 Submitted Manuscript version 6
27 Jan 2023 Reviewed Reviewer Report
7 Feb 2023 Reviewed Reviewer Report
13 Feb 2023 Author responded Author comments - Wenhao Guo
Resubmission - Version 7
13 Feb 2023 Submitted Manuscript version 7
21 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
22 Feb 2023 Editorially accepted
28 Mar 2023 Article published 10.1186/s40360-023-00655-0

You can find further information about peer review here.

Back to article page